Wishpond
Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Trending >

ADVERTISE WITH CANTECH

TOP PICKS

TH Stock

TH Stock Price

TH Stock News

Cantech Letter's 2015 Life Sciences Stock of the Year

In the Canadian Life Sciences sector, 2015 was defined by one word: Valeant. Valeant Pharmaceuticalâ... Read More

THTX stock

Shares of Theratechnologies (TSX:TH) are down slightly today after the company reported its Q1, 2015... Read More

Theratechnologies

It would be an understatement to say that specialty pharma companies have been popular among Canadia... Read More

THTX stock

Shares of Theratechnologies (Theratechnologies Stock Quote, Chart, News: TSX:TH) have slid from high... Read More

Theratechnologies

Theratechnologies (Theratechnologies Stock Quote, Chart, News: TSX:TH) today announced it has filed ... Read More

Yesterday, Theratechnologies (TSX:TH) received some bad news as Egrifta, its tesamorelin application... Read More

A vinyl wrapped awareness display for Egrifta in Manhattan's Chelsea District. Byron Capital's Douglas Loe says he is optimistic about Egrifta's potential, but that regulatory risk in the Latin American and European markets remains a concern.

Theratechnologies (TSX:TH) this morning reported its fiscal 2012 results. The company lost $13.94-mi... Read More

Shares of Theratechnologies (TSX:TH) rose in Toronto on Wednesday after providing investors with an ... Read More

Byron Capital healthcare analyst Douglas Loe says data coming out of ENDO, the Endocrine Society conference that wrapped up yesterday in Houston, is incongruous with the Theratechnologies E.U. regulatory challenges.

ENDO, the annual meeting of The Endocrine Society wrapped up its 2012 session in Houston yesterday. ... Read More

Byron Capital Healthcare analyst Douglas Loe says the reason for Ferrer's withdrawal in Europe, concerns about long-term cardiovascular safety concerns from elevating IGF-1 blood levels generated by Egrifta use, is particularly bad.

Bad news for shareholders of Theratechnologies (TSX:TH) today. Shares of the Quebec-based biotech we... Read More

Byron Capital's Douglas Loe says the launch of Egrifta has been slower than expected, but should accelerate in 2012.

On Friday, Theratechnologies (TSX:TH) reported its Q1 2012 results. Revenue came in at $3.19-million... Read More

Toronto IT player Softchoice has also been on a tear of late, spiking from $8 in October to $13 today. But CEO David MacDonald is still buying shares.

There is one quote you hear more often than any other on the subject of insider buying. It is from l... Read More

Jay Nalbach (left) and Ken Barker from Naturally Advanced Technologies. The company today announced it has hired industry veteran Ralph Fisher as a regional agronomic advisor.

Wavefront Technology (TSXV:WEE) announced its Q1,2012 results. Revenues came in at $1,111,555, which... Read More

There are many people who believe Canadian technology stocks are undervalued. Of course, as John May... Read More

Canadian Stock News Cantech

It's been nearly a century since Canada's greatest achievement in biotech took place; the discovery ... Read More

It’s been nearly a century since Canada’s greatest achievement in biotech took place; th... Read More

Canadian Stock News Cantech

At the end of this month, the company announced in October, Yves Rosconi is out the door as Theratec... Read More

Canadian Stock News Cantech

Tomorrow’s Leaders: Ten Canadian Tech Stocks for the Future At Cantech Letter we like value. T... Read More

MORE ARTICLES

TH:CA Key Financial Ratios

TH:CA Financial Statistics

Share Tweet pinterest pin linked In Share

Get Stock Picks from the Pros.
In your Inbox.